STAT

APRIL 4, 2024

  The price of Humira rose 470% in the 20 years following its launch in 2003 to reach upward of $84,000 annually. List prices of Humira biosimilars are as much as 85% lower.    Continue to STAT+ to read the full story…

Biosimilars 362

Biosimilars Drug Pricing 362

STAT

JULY 6, 2023

Advertisements eviscerating and glorifying pharmacy benefit managers have been around for years, but have intensified over the past three months as Congress scrutinizes the role these middlemen play in shaping high prescription drug prices , STAT tells us.

Drug Pricing 232

Drug Pricing Vaccines Diabetes Pharmaceutical Companies 232

FDA Law Blog: Biosimilars

MARCH 18, 2025

Even though the PTE provisions established in the Drug Price Competition and Patent Restoration Act are forty-plus years old, courts are still grappling with questions about how to best implement the Patent Term Extension.

Drug Pricing 59

Drug Pricing Pharmaceutical Companies Pharmaceutical Companies 59

Putting Patients First Blog

NOVEMBER 14, 2023

NHC Comments on Request for Information: Medicare Transaction Facilitator (MTF) for the Medicare Drug Price Negotiation Program (PDF) November 13, 2023 Benjamin Stidham, Contract Specialist Centers for Medicare & Medicaid Services U.S. Drug Distribution Data 2019. 5 Salako, A., Ullrich, F., and Mueller, K. Alexandr, G.,

Drug Pricing 40

Drug Pricing Specialty Pharmacies HIPAA Payment Processing 40

Putting Patients First Blog

MAY 1, 2023

About Beyond Celiac Since 2003, Beyond Celiac has been the leading patient advocacy and research-driven celiac disease organization working to drive diagnosis, advance research and accelerate the discovery of new treatments and a cure. Beyond Celiac is here to help.

Drug Pricing 83

Drug Pricing 83

Big Molecule Watch

AUGUST 25, 2023

The Inflation Reduction Act’s Medicare Drug Price Negotiation Program will kick off next week. There are reports that the White House may announce the list of selected drugs even before that deadline, on Tuesday, August 29 th. Before the IRA, the government could not set prices for any drugs covered by Medicare.

Drug Pricing 40

Drug Pricing Biosimilars Insurance Coverage and Processing Labelling 40

pharmaphorum

JULY 26, 2021

The numbers are striking – in just the 13 years following 2003, R&D costs were estimated to have doubled , and with failure rates as high as 90% and time to market stagnating at ~12 years for the past three decades , the R&D innovation need is urgent.

Drug Pricing 52

Drug Pricing Drug Development 52